Steven T. DeKosky
#23,806
Most Influential Person Now
American medical researcher
Steven T. DeKosky's AcademicInfluence.com Rankings
Steven T. DeKoskymedical Degrees
Medical
#164
World Rank
#249
Historical Rank
Neurology
#12
World Rank
#31
Historical Rank
Steven T. DeKoskyphilosophy Degrees
Philosophy
#3478
World Rank
#5613
Historical Rank
Logic
#1206
World Rank
#1897
Historical Rank
Download Badge
Medical Philosophy
Steven T. DeKosky's Degrees
- Doctorate Medicine University of Cincinnati
- PhD Pharmacology University of Cincinnati
Why Is Steven T. DeKosky Influential?
(Suggest an Edit or Addition)According to Wikipedia, Steven T. DeKosky is the Aerts-Cosper Professor of Alzheimer's Research at the University of Florida College of Medicine, deputy director of UF’s Evelyn F. and William L. McKnight Brain Institute and associate director of the 1Florida Alzheimer’s Disease Research Center.
Steven T. DeKosky's Published Works
Published Works
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) (6818)
- Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria (2007) (4004)
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria (2014) (2513)
- Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) (2001) (2115)
- Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity (1990) (2054)
- Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. (2002) (1832)
- Revising the definition of Alzheimer's disease: a new lexicon (2010) (1793)
- Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) (1656)
- Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. (2000) (1394)
- Practice parameter: Diagnosis of dementia (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology (2001) (1258)
- Practice parameter: Diagnosis of dementia (an evidence-based review) (2001) (1178)
- Treatment of traumatic brain injury with moderate hypothermia. (1997) (1048)
- Frequent amyloid deposition without significant cognitive impairment among the elderly. (2008) (978)
- Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans (2006) (968)
- Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. (1997) (924)
- Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease (2008) (888)
- [11C]PIB in a nondemented population (2006) (767)
- Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease (2009) (701)
- Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment (2007) (695)
- Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B (2005) (677)
- Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. (2003) (639)
- Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment (2002) (638)
- Ginkgo biloba for prevention of dementia: a randomized controlled trial. (2008) (593)
- CHRONIC TRAUMATIC ENCEPHALOPATHY IN A NATIONAL FOOTBALL LEAGUE PLAYER: PART II (2005) (573)
- Assessing the Impact of Neuropsychiatric Symptoms in Alzheimer's Disease: The Neuropsychiatric Inventory Caregiver Distress Scale (1998) (552)
- Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. (2005) (546)
- Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. (2003) (513)
- Vascular cognitive impairment (2002) (512)
- Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging (1998) (504)
- Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. (2003) (484)
- Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions (2010) (475)
- Potential antecedent marker of Alzheimer disease (2006) (474)
- The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging and Alzheimer's Association workgroup (2011) (441)
- Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment (2001) (438)
- Dementia and Alzheimer's Disease Incidence in Relationship to Cardiovascular Disease in the Cardiovascular Health Study Cohort (2005) (438)
- Pathways linking late-life depression to persistent cognitive impairment and dementia (2008) (423)
- Quantitative assessment of cortical synaptic density in Alzheimer's disease (1990) (419)
- Mild cognitive impairment, amnestic type (2004) (416)
- Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented (2000) (411)
- Traumatic Brain Injury‐Induced Excitotoxicity Assessed in a Controlled Cortical Impact Model (1993) (409)
- Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery—2018 (2018) (401)
- Imaging of amyloid burden and distribution in cerebral amyloid angiopathy (2007) (398)
- Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-β in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain (2005) (384)
- Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. (2001) (382)
- Structural correlates of cognition in dementia: quantification and assessment of synapse change. (1996) (380)
- Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury (2004) (378)
- A hindi version of the MMSE: The development of a cognitive screening instrument for a largely illiterate rural elderly population in india (1995) (373)
- P2-366 Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees (2006) (367)
- Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. (2007) (349)
- Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders (2003) (328)
- Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. (2000) (321)
- Amyloid imaging in mild cognitive impairment subtypes (2009) (320)
- The temporal relationship between depressive symptoms and dementia: a community-based prospective study. (1999) (318)
- A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphism (1995) (316)
- Cognitive correlates of cortical cholinergic denervation in Parkinson’s disease and parkinsonian dementia (2006) (315)
- Appendix B: Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the quality standards subcommittee of the American academy neurology (2007) (314)
- Incidence of Alzheimer’s disease in a rural community in India (2001) (301)
- The Binding of 2-(4′-Methylaminophenyl)Benzothiazole to Postmortem Brain Homogenates Is Dominated by the Amyloid Component (2003) (293)
- Prevalence of Alzheimer's disease and other dementias in rural India (1998) (285)
- One-year study of spatial memory performance, brain morphology, and cholinergic markers after moderate controlled cortical impact in rats. (1999) (284)
- Recommendations for the Nomenclature of Cognitive Change Associated with Anaesthesia and Surgery—2018 (2018) (283)
- Traumatic brain injury: football, warfare, and long-term effects. (2010) (282)
- Common variants at MS 4 A 4 / MS 4 A 6 E , CD 2 AP , CD 33 and EPHA 1 are associated with late-onset Alzheimer ’ s disease (2011) (274)
- Recognition and discrimination of emotional faces and pictures (1980) (269)
- Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction (2003) (269)
- Alzheimer disease and mortality: a 15-year epidemiological study. (2005) (265)
- Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease (2002) (264)
- Psychiatric symptoms vary with the severity of dementia in probable Alzheimer's disease. (2003) (264)
- Chronic traumatic encephalopathy (CTE) in a National Football League Player: Case report and emerging medicolegal practice questions (2010) (250)
- Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. (2009) (246)
- 22R-Hydroxycholesterol and 9-cis-Retinoic Acid Induce ATP-binding Cassette Transporter A1 Expression and Cholesterol Efflux in Brain Cells and Decrease Amyloid β Secretion* (2003) (241)
- Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease (2009) (238)
- Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease (1996) (232)
- Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers (2013) (230)
- Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias (1999) (229)
- Genome-wide association study of Alzheimer's disease (2012) (220)
- Associations of gait speed and other measures of physical function with cognition in a healthy cohort of elderly persons. (2007) (218)
- Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. (1997) (213)
- Sex, Apolipoprotein E ε4 Status, and Hippocampal Volume in Mild Cognitive Impairment (2005) (212)
- Basal Cerebral Metabolism May Modulate the Cognitive Effects of Aβ in Mild Cognitive Impairment: An Example of Brain Reserve (2009) (212)
- Awareness of cognitive deficits and anosognosia in probable Alzheimer's disease. (1994) (211)
- Ten-year incidence of dementia in a rural elderly US community population (2000) (200)
- Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer’s disease (2008) (199)
- Mild cognitive impairment: pathology and mechanisms (2011) (190)
- Differential cortical atrophy in subgroups of mild cognitive impairment. (2005) (189)
- Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease. (1999) (182)
- Chronic Traumatic Encephalopathy in a National Football League Player. (2006) (181)
- Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease (2009) (180)
- Early neuropathologic effects of mild or moderate hypoxemia after controlled cortical impact injury in rats. (1997) (177)
- Neuropsychological characteristics of mild cognitive impairment subgroups (2005) (177)
- Apoptotic interactions of cytochrome c: redox flirting with anionic phospholipids within and outside of mitochondria. (2006) (174)
- Hypothermia attenuates the normal increase in interleukin 1 beta RNA and nerve growth factor following traumatic brain injury in the rat. (1995) (171)
- Practice parameter: Management of dementia (an evidence-based review) (2001) (169)
- Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease. (2009) (168)
- Determinants of vascular dementia in the Cardiovascular Health Cognition Study (2005) (167)
- Caregiving burden and psychiatric morbidity in spouses of persons with mild cognitive impairment (2005) (165)
- Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study (2008) (164)
- Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer’s disease (2005) (162)
- Interleukin‐8 is increased in cerebrospinal fluid of children with severe head injury (2000) (161)
- The Type 1 Interleukin-1 Receptor Is Essential for the Efficient Activation of Microglia and the Induction of Multiple Proinflammatory Mediators in Response to Brain Injury (2002) (161)
- A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type. (2005) (160)
- PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders. (1999) (159)
- Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study. (2007) (157)
- The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. (2006) (155)
- Elevated corticosterone levels. A possible cause of reduced axon sprouting in aged animals. (1984) (152)
- Mild Posttraumatic Hypothermia Reduces Mortality after Severe Controlled Cortical Impact in Rats (1996) (152)
- Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults (2013) (150)
- Astrocytes Are the Major Source of Nerve Growth Factor Upregulation Following Traumatic Brain Injury in the Rat (1998) (150)
- Research evaluation and diagnosis of possible Alzheimer’s disease over the last two decades: II (2000) (149)
- Arterial stiffness and β-amyloid progression in nondemented elderly adults. (2014) (146)
- Analysis of genetic polymorphisms in the transforming growth factor-β1 gene and the risk of Alzheimer's disease (2000) (146)
- Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease. (1998) (144)
- Research evaluation and prospective diagnosis of dementia with Lewy bodies. (2002) (143)
- Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. (2011) (142)
- Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans. (2007) (141)
- Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. (2014) (140)
- Association between dementia and elevated TSH: A community-based study (1996) (139)
- Trajectories of cognitive decline in Alzheimer's disease (2009) (139)
- Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial (2002) (138)
- Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology. (2003) (136)
- Increased transmitter amino acid concentration in human ventricular CSF after brain trauma (1994) (135)
- The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease (2020) (133)
- Antihypertensive drugs decrease risk of Alzheimer disease (2013) (131)
- Imaging Alzheimer Pathology in Late-Life Depression With PET and Pittsburgh Compound-B (2008) (129)
- Upregulation of Nerve Growth Factor Following Cortical Trauma (1994) (128)
- Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice (1999) (128)
- Reduced binding of [ 18 F ]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction (1998) (128)
- Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease (2006) (124)
- Detection and Management of Cognitive Impairment in Primary Care: The Steel Valley Seniors Survey (2004) (124)
- Research evaluation and diagnosis of probable Alzheimer’s disease over the last two decades: I (2000) (123)
- Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study. (2012) (123)
- Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury (2014) (120)
- Increased 5-Lipoxygenase Immunoreactivity in the Hippocampus of Patients With Alzheimer's Disease (2008) (120)
- Recollection and familiarity in amnestic mild cognitive impairment: A global decline in recognition memory (2008) (120)
- Volumetric atrophy of the amygdala in Alzheimer's disease (1991) (119)
- Hippocampal plasticity during the progression of Alzheimer’s disease (2015) (117)
- Making sense of mild cognitive impairment: a qualitative exploration of the patient's experience. (2006) (117)
- Gender-specific aging effects on the serotonin 1A receptor (2001) (116)
- Extrapyramidal signs in patients with probable Alzheimer disease. (1997) (116)
- Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. (2001) (115)
- Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. (2005) (115)
- Diffusion tensor imaging (DTI) findings in adult civilian, military, and sport-related mild traumatic brain injury (mTBI): a systematic critical review (2018) (114)
- Genome-wide Association Study of Alzheimer’s disease with Psychotic Symptoms (2011) (114)
- Consideration of Optimal Time Window for Pittsburgh Compound B PET Summed Uptake Measurements (2009) (114)
- Gonadal steroids influence axon sprouting in the hippocampal dentate gyrus: A sexually dimorphic response (1986) (112)
- Hypothyroidism and cognition: preliminary evidence for a specific defect in memory. (2001) (111)
- Alteration of a Clinically Meaningful Outcome in the Natural History of Alzheimer's Disease by Cholinesterase Inhibition (2005) (110)
- Interleukm‐1 receptor antagonist suppresses neurotrophin response in injured rat brain (1996) (109)
- The 5-HTTPR Polymorphism Confers Liability to a Combined Phenotype of Psychotic and Aggressive Behavior in Alzheimer Disease (2001) (109)
- Toward the treatment and prevention of Alzheimer's disease: rational strategies and recent progress. (2013) (109)
- The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease. (2013) (107)
- The "pro-apoptotic genies" get out of mitochondria: oxidative lipidomics and redox activity of cytochrome c/cardiolipin complexes. (2006) (107)
- Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functional fetal nigral implants. (1997) (106)
- Reliability of NINDS‐AIREN clinical criteria for the diagnosis of vascular dementia (1994) (106)
- Recommendations for the Nomenclature of Cognitive Change Associated With Anaesthesia and Surgery—2018 (2018) (106)
- Neuropathologic Correlates of Late-Onset Major Depression (2004) (105)
- Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's disease (2005) (105)
- APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. (1995) (104)
- Classification of vascular dementia in the Cardiovascular Health Study Cognition Study (2005) (103)
- Computed tomography--but not magnetic resonance imaging--identified periventricular white-matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's disease. (1995) (102)
- Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease. (2007) (102)
- Herpes Simplex Virus Type 1 Vector-Mediated Expression of Nerve Growth Factor Protects Dorsal Root Ganglion Neurons from Peroxide Toxicity (1999) (101)
- Research Gaps and Controversies in Chronic Traumatic Encephalopathy: A Review (2017) (101)
- Aberrant Expression of Myeloperoxidase in Astrocytes Promotes Phospholipid Oxidation and Memory Deficits in a Mouse Model of Alzheimer Disease* (2009) (101)
- Patterns of mild cognitive impairment after treatment of depression in the elderly. (2009) (100)
- The 5-HTTPR*S/*L polymorphism and aggressive behavior in Alzheimer disease. (2001) (99)
- Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. (1999) (99)
- Changes in expression of amyloid precursor protein and interleukin-1beta after experimental traumatic brain injury in rats. (2002) (99)
- Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia (2009) (96)
- Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease (2000) (96)
- Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease (1998) (95)
- Caspase inhibition therapy abolishes brain trauma-induced increases in Aβ peptide: Implications for clinical outcome (2006) (94)
- Alzheimer's disease: The right drug, the right time (2018) (94)
- Genome-wide association analysis of age-at-onset in Alzheimer's disease (2012) (93)
- Amygdala cell loss and atrophy in Alzheimer's disease (1992) (93)
- Assessing Utility of Single Photon Emission Computed Tomography (SPECT) Scan in Alzheimer Disease: Correlation with Cognitive Severity (1990) (92)
- In vivo assessment of amyloid‐β deposition in nondemented very elderly subjects (2013) (92)
- Cytochrome c, a Biomarker of Apoptosis, is Increased in Cerebrospinal Fluid from Infants with Inflicted Brain Injury from Child Abuse (2005) (92)
- Dementia with Lewy bodies (1998) (89)
- Monoamine neurons in aging and Alzheimer's disease (2005) (89)
- Plasma and cerebrospinal fluid α1‐antichymotrypsin levels in Alzheimer's disease: Correlation with cognitive impairment (2003) (88)
- Increased familial risk of the psychotic phenotype of Alzheimer disease (2002) (88)
- Concomitant Use of Prescription Drugs and Dietary Supplements in Ambulatory Elderly People (2009) (88)
- Heritability of psychosis in Alzheimer disease. (2005) (87)
- Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene (1998) (87)
- Simvastatin therapy prevents brain trauma‐induced increases in β‐amyloid peptide levels (2009) (86)
- The effect of brain temperature on acute inflammation after traumatic brain injury in rats. (1997) (86)
- Incidence of mild cognitive impairment in the Pittsburgh Cardiovascular Health Study–Cognition Study (2012) (85)
- The World of Dementia Beyond 2020 (2011) (85)
- Association of CLU and PICALM variants with Alzheimer's disease (2012) (84)
- The Antioxidant Enzymes Glutathione Peroxidase and Catalase Increase Following Traumatic Brain Injury in the Rat (1997) (84)
- Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study (2012) (83)
- Embryonic neural cell adhesion molecule (N-CAM) is elevated in the denervated rat dentate gyrus (1994) (81)
- Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease (2002) (79)
- Neutrophils do not mediate blood-brain barrier permeability early after controlled cortical impact in rats. (1999) (77)
- Cholinergic forebrain degeneration in the APPswe/PS1ΔE9 transgenic mouse (2007) (76)
- Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. (2011) (76)
- Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease (2011) (76)
- Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B (2008) (76)
- Soluble adhesion molecules in CSF are increased in children with severe head injury. (1998) (75)
- Functional transitions and active life expectancy associated with Alzheimer disease. (2003) (75)
- Classification of amyloid-positivity in controls: Comparison of visual read and quantitative approaches (2013) (74)
- Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease (2005) (74)
- Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging (1985) (74)
- Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia (2013) (74)
- A medial temporal lobe division of labor: Insights from memory in aging and early Alzheimer disease (2011) (73)
- Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies (2000) (73)
- Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease (2007) (72)
- Recruitment of the elderly into a pharmacologic prevention trial: the Ginkgo Evaluation of Memory Study experience. (2006) (72)
- Incidence and predictors of advance care planning among persons with cognitive impairment. (2010) (72)
- The psychotic phenomenon in probable Alzheimer's disease: a positron emission tomography study. (2001) (71)
- Marital Quality in the Context of Mild Cognitive Impairment (2007) (71)
- Imaging technology for neurodegenerative diseases: progress toward detection of specific pathologies. (2005) (71)
- Predictors of progression in patients with AD and Lewy bodies (2000) (71)
- Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease. (2005) (70)
- Quinolinic Acid is Increased in CSF and Associated with Mortality after Traumatic Brain Injury in Humans (1998) (70)
- Markers of cholesterol transport are associated with amyloid deposition in the brain (2014) (70)
- Neurotrophic effects of steroids on lesion-induced growth in the hippocampus II. Hormone replacement (1992) (69)
- Alcohol Consumption and Risk of Dementia and Cognitive Decline Among Older Adults With or Without Mild Cognitive Impairment (2019) (69)
- Expert consensus document: Mind the gaps—advancing research into short-term and long-term neuropsychological outcomes of youth sports-related concussions (2015) (69)
- Glymphatic system disruption as a mediator of brain trauma and chronic traumatic encephalopathy (2018) (69)
- Alterations of striatal dopamine receptor binding in Alzheimer disease are associated with Lewy body pathology and antemortem psychosis. (2001) (69)
- Expression of differential immune factors in temporal cortex and cerebellum: The role of α‐1‐antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease (1998) (68)
- Cerebral [18 F]T807/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathy (2016) (67)
- Development of a short form of the Severe Impairment Battery. (2005) (67)
- Small head size is related to low Mini-Mental State Examination scores in a community sample of nondemented older adults (1999) (67)
- Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures (2006) (66)
- Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease. (2009) (66)
- Psychotic symptoms in Alzheimer disease: evidence for subtypes. (2003) (65)
- 2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease (2014) (65)
- Is the urea cycle involved in Alzheimer's disease? (2010) (65)
- Injury cascades in TBI-related neurodegeneration (2017) (65)
- Hippocampal volume is associated with memory but not nonmemory cognitive performance in patients with mild cognitive impairment (2007) (64)
- Anticipatory Grief in New Family Caregivers of Persons With Mild Cognitive Impairment and Dementia (2012) (64)
- Regional distribution of neural cell adhesion molecule (N‐CAM) and L1 in human and rodent hippocampus (1993) (64)
- Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. (2003) (63)
- The apolipoprotein E ϵ4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease (1997) (63)
- Antibodies against Mac-1 attenuate neutrophil accumulation after traumatic brain injury in rats. (1996) (62)
- Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease. (2007) (62)
- Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression (2005) (62)
- Oxidative lipidomics of programmed cell death. (2008) (62)
- Perinatal glucocorticoids disrupt learning: A sexually dimorphic response (1986) (61)
- Phenotypic variability in three families with valosin‐containing protein mutation (2013) (60)
- Diabetes and Cognitive Decline in Older Adults: The Ginkgo Evaluation of Memory Study (2017) (60)
- Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology (2002) (60)
- Longitudinal increase in the volume of white matter hyperintensities in late‐onset depression (2002) (59)
- Alzheimer disease with psychosis: excess cognitive impairment is restricted to the misidentification subtype. (2004) (59)
- Early Intervention Is Key to Successful Management of Alzheimer Disease (2003) (58)
- Psychiatric symptoms associated with cortical-subcortical dysfunction in Alzheimer's disease. (2001) (58)
- EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease (1997) (58)
- Chronic traumatic encephalopathy: clinical‐biomarker correlations and current concepts in pathogenesis (2014) (57)
- Linkage analysis of Alzheimer disease with psychosis (2002) (57)
- Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse. (2007) (57)
- Studies of the epidemiology of dementia: Comparisons between developed and developing countries (1994) (56)
- Association of Brain Amyloid-&bgr; With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E &egr;4 Genotype (2017) (56)
- Infection Hospitalization Increases Risk of Dementia in the Elderly* (2014) (56)
- Morphologic and behavioral effects of perinatal glucocorticoid administration (1982) (56)
- Factors Influencing Clinical Correlates of Chronic Traumatic Encephalopathy (CTE): a Review (2016) (56)
- Association of the 3′ UTR transcription factor LBP‐1c/CP2/LSF polymorphism with late‐onset Alzheimer's disease (2003) (55)
- Blood pressure and cognitive impairment in India and the United States: a cross-national epidemiological study. (2003) (55)
- Psychotic Symptoms in Alzheimer's Disease Are Not Associated With More Severe Neuropathologic Features (2000) (55)
- The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. (2010) (55)
- Chronic Effects of Traumatic Brain Injury on Hippocampal Vesicular Acetylcholine Transporter and M2Muscarinic Receptor Protein in Rats (1998) (55)
- Changes in hippocampal GABABR1 subunit expression in Alzheimer’s patients: association with Braak staging (2005) (54)
- Steroid suppression of axon sprouting in the hippocampal dentate gyrus of the adult rat: Dose-response relationship (1983) (54)
- The Relation of White Matter Hyperintensities to Cognitive Performance in the Normal Old: Education Matters (2006) (54)
- Genetic determinants of disease progression in Alzheimer's disease. (2014) (53)
- Strain comparison of synaptic density in hippocampal CA1 of aged rats (1985) (53)
- Reactive synaptogenesis in hippocampal area CA1 of aged and young adult rats (1986) (53)
- Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease (2006) (52)
- Quantitation of synaptic density in the septal nuclei of young and aged Fischer 344 rats (1991) (52)
- The Use of MRI and PET for Clinical Diagnosis of Dementia and Investigation of Cognitive Impairment : A Consensus Report (2004) (52)
- The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis (2009) (51)
- Investigation of oxidized LDL-receptor 1 (OLR1) as the candidate gene for Alzheimer's disease on chromosome 12 (2002) (51)
- Frequency and correlates of advance planning among cognitively impaired older adults. (2008) (51)
- X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease. (2006) (51)
- Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex (2005) (51)
- Investigation of antihypertensive class, dementia, and cognitive decline (2019) (51)
- Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old (2014) (51)
- Pathology and Pathways of Alzheimer's Disease with an Update on New Developments in Treatment (2003) (51)
- Resuscitation from severe brain trauma. (1996) (50)
- Use of Herbal Medicine and Other Dietary Supplements in Community‐Dwelling Older People: Baseline Data from the Ginkgo Evaluation of Memory Study (2006) (50)
- APOE is associated with age‐of‐onset, but not cognitive functioning, in late‐life depression (2003) (50)
- Amyloid imaging in dementias with atypical presentation (2012) (50)
- A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease (2019) (50)
- Functional neuroanatomy of verbal free recall: A replication study (1994) (50)
- Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients (2020) (49)
- Evidence supporting a role for the calcium‐sensing receptor in Alzheimer disease (2009) (49)
- Revision of the criteria for Alzheimer's disease: A symposium (2011) (49)
- Functional Connectivity in Auditory–Verbal Short-Term Memory in Alzheimer's Disease (1996) (48)
- Statin therapy in the treatment of Alzheimer disease: what is the rationale? (2005) (48)
- Alternate strategies in lesion-induced reactive synaptogenesis: differetial expression of L1 in two populations of sprouting axons (1995) (48)
- Association of 3′-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer’s disease (2003) (48)
- Hemoglobin levels and Alzheimer disease: an epidemiologic study in India. (2004) (48)
- Galanin Fiber Hypertrophy within the Cholinergic Nucleus Basalis during the Progression of Alzheimer’s Disease (2006) (47)
- Symptoms of depression and psychosis in Alzheimer's disease and frontotemporal dementia : Exploration of underlying mechanisms (1996) (46)
- Recommendations for the Nomenclature of Cognitive Change Associated with Anaesthesia and Surgery-20181. (2018) (46)
- Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease (2005) (45)
- Methodological issues in primary prevention trials for neurodegenerative dementia. (2009) (44)
- Alzheimer's disease. Aminergic-cholinergic alterations in hypothalamus. (1988) (44)
- An immunohistochemical study of GABAA receptor gamma subunits in Alzheimer's disease hippocampus: Relationship to neurofibrillary tangle progression (2009) (44)
- Prediction of psychosis onset in Alzheimer disease: The role of cognitive impairment, depressive symptoms, and further evidence for psychosis subtypes. (2006) (44)
- Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African‐Americans (2003) (43)
- No association between CALHM1 variation and risk of Alzheimer disease (2009) (43)
- Rapid expression and transport of embryonic N‐CAM in dentate gyrus following entorhinal cortex lesion: Ultrastructural analysis (1994) (42)
- Increased Phosphorylation of Protein Kinase B and Related Substrates after Traumatic Brain Injury in Humans and Rats (2006) (42)
- The Role of Resting-State Network Functional Connectivity in Cognitive Aging (2020) (41)
- Cognitive and behavioral correlates of low vitamin B12 levels in elderly patients with progressive dementia. (2002) (41)
- Alzheimer Disease: Diagnosis, Costs, and Dimensions of Treatment (2001) (41)
- Registries and Cohorts to Accelerate Early Phase Alzheimer's Trials. A Report from the E.U./U.S. Clinical Trials in Alzheimer's Disease Task Force. (2016) (41)
- Genetic association studies of interleukin‐1 (IL‐1A and IL‐1B) and interleukin‐1 receptor antagonist genes and the risk of Alzheimer's disease (2000) (40)
- Monoaminergic and cholinergic synaptic markers in the nucleus basalis of meynert (nbM): Normal age‐related changes and the effect of heart disease and Alzheimer's disease (1992) (40)
- Time course analysis of hippocampal nerve growth factor and antioxidant enzyme activity following lateral controlled cortical impact brain injury in the rat. (2004) (40)
- Diagnostic criteria for apathy in neurocognitive disorders (2021) (40)
- The Th1 versus Th2 cytokine profile in cerebrospinal fluid after severe traumatic brain injury in infants and children (2001) (40)
- Aging, senile dementia, and the intralaminar microchemistry of cerebral cortex (1982) (39)
- Rarity of the Alzheimer disease-protective APP A673T variant in the United States. (2015) (39)
- No association of SORL1 SNPs with Alzheimer's disease (2008) (39)
- Right prosubiculum amyloid plaque density correlates with anosognosia in Alzheimer’s disease (2004) (39)
- Inflammatory Biomarkers Predict Domain-Specific Cognitive Decline in Older Adults (2016) (39)
- Genetic variation in α1-antichymotrypsin and its association with Alzheimer’s disease (2002) (38)
- Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment (2018) (38)
- Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure (2020) (38)
- Augmented neuronal death in CA3 hippocampus following hyperventilation early after controlled cortical impact. (1998) (38)
- A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease (1999) (38)
- Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease (2006) (38)
- Valsartan/Sacubitril for Heart Failure: Reconciling Disparities Between Preclinical and Clinical Investigations. (2016) (38)
- Oxidative lipidomics of apoptosis: quantitative assessment of phospholipid hydroperoxides in cells and tissues. (2010) (37)
- Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer's disease (2005) (37)
- Practical issues in cognitive screening of elderly illiterate populations in developing countries. The Indo-US Cross-National Dementia Epidemiology Study (1998) (37)
- Does Ginkgo biloba Reduce the Risk of Cardiovascular Events? (2010) (36)
- Comparison of the interleukin-6 and interleukin-10 response in children after severe traumatic brain injury or septic shock. (1997) (36)
- Cognitive stability over 2 years in a rural elderly population: the MoVIES project. (1996) (35)
- Acute Blast Injury Reduces Brain Abeta in Two Rodent Species (2012) (35)
- Chronic traumatic encephalopathy in a National Football League player. (2005) (35)
- Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery—2018 (2018) (35)
- Glucocorticoid suppression of lesion-induced synaptogenesis: Effect of temporal manipulation of steroid treatment (1989) (34)
- Traumatic brain injury--football, warfare, and long-term effects. (2010) (33)
- APOE ε4 Status and Traumatic Brain Injury on the Gridiron or the Battlefield (2012) (33)
- Differential effects of traumatic brain injury on vesicular acetylcholine transporter and M2 muscarinic receptor mRNA and protein in rat. (1999) (32)
- Epidemiology and pathophysiology of Alzheimer's disease. (2001) (31)
- Evidence for the association of the S100β gene with low cognitive performance and dementia in the elderly (2007) (31)
- Dual sensory impairment in older adults and risk of dementia from the GEM Study (2020) (31)
- Serum anticholinergic activity, white matter hyperintensities, and cognitive performance (2005) (31)
- Free-water imaging of the hippocampus is a sensitive marker of Alzheimer's disease (2019) (30)
- Amyloid &bgr; Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia (2018) (30)
- Amyloid deposition and brain structure as long-term predictors of MCI, dementia, and mortality (2018) (30)
- [18F]-T807 tauopathy PET imaging in chronic traumatic encephalopathy (2014) (30)
- Impact of Amyloid PET Imaging in the Memory Clinic: A Systematic Review and Meta-Analysis. (2018) (29)
- Up‐Regulation of Type 2 Iodothyronine Deiodinase mRNA in Reactive Astrocytes Following Traumatic Brain Injury in the Rat (1998) (29)
- The relation of White Matter Hyperintensities to implicit learning in healthy older adults (2002) (28)
- CME Practice parameter : Early detection of dementia : Mild cognitive impairment ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology (2001) (28)
- Validation of consensus panel diagnosis in dementia. (2010) (28)
- Chronic traumatic encephalopathy in a national football league player. Part II. Commentary (2005) (27)
- Relationship between apoE4 allele and excitatory amino acid levels after traumatic brain injury (2003) (27)
- Cognitive test scores in community-based older adults with and without dementia (1997) (27)
- Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. (2006) (27)
- Lack of association between α2-macroglobulin polymorphisms and Alzheimer's disease (2001) (26)
- Prediction of psychosis onset in Alzheimer disease: The role of depression symptom severity and the HTR2A T102C polymorphism (2007) (25)
- Comparison of the amyloid imaging agents [F-18]3'-F-PIB and [C-11]PIB in Alzheimer's disease and control subjects (2007) (25)
- Cortical pyroglutamate amyloid-β levels and cognitive decline in Alzheimer's disease (2015) (25)
- Replication study of genome‐wide associated SNPs with late‐onset Alzheimer's disease (2011) (25)
- Identifying mild cognitive impairment at baseline in the Ginkgo Evaluation of Memory (GEM) study (2009) (24)
- Environmental exposures and the risk for Alzheimer disease: can we identify the smoking guns? (2014) (24)
- Vascular cognitive impairment. (2001) (24)
- Memory Impairment in Elderly Individuals With a Mildly Elevated Serum TSH: The Role of Processing Resources, Depression and Cerebrovascular Disease (2002) (24)
- The apolipoprotein E epsilon 4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease. (1997) (23)
- CR1 and the “Vanishing Amyloid” Hypothesis of Alzheimer’s Disease (2013) (23)
- Anti-Amyloid Effects of Small Molecule Aβ-Binding Agents in PS1/APP Mice. (2009) (23)
- Genetic association of two chromosome 14 genes (presenilin 1 and α1‐Antichymotrypsin) with Alzheimer's disease (1998) (23)
- Immunohistochemical study of the hnRNP A2 and B1 in the hippocampal formations of brains with Alzheimer's disease (2005) (23)
- Psychiatric correlates of MR deep white matter lesions in probable Alzheimer's disease. (1997) (23)
- Brain health INnovation Diplomacy: a model binding diverse disciplines to manage the promise and perils of technological innovation (2020) (23)
- Recovery from Proactive Semantic Interference and MRI Volume: A Replication and Extension Study. (2017) (23)
- Effects of post‐injury hypothermia and nerve growth factor infusion on antioxidant enzyme activity in the rat: implications for clinical therapies (2004) (23)
- Diuretic use is associated with better learning and memory in older adults in the Ginkgo Evaluation of Memory study (2012) (22)
- Concussion Biomarkers Assessed in Collegiate Student-Athletes (BASICS) I (2018) (22)
- Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification (2021) (22)
- Cause of Death and End‐of‐Life Experiences in Individuals with Dementia with Lewy Bodies (2018) (22)
- Clinical symptoms in Alzheimer's disease. (2008) (22)
- Neurologic Factors Associated with Cognitive Impairment in a Rural Elderly Population in India: The Indo-US Cross-National Dementia Epidemiology Study (1998) (22)
- Apolipoproteins and Alzheimer's pathophysiology (2018) (21)
- Altered striatal dopaminergic metabolism 36 hours after unilateral trauma to the human mesencephalon (1987) (21)
- Relationship between CSF neurotransmitter metabolites and aggressive behavior in Alzheimer's disease (1996) (21)
- Perinatal glucocorticoids alter dentate gyrus electrophysiology (1985) (21)
- Frontotemporal dementia associated with a Valosin‐Containing Protein mutation: report of three families (2008) (21)
- Development of a transcallosal tractography template and its application to dementia (2019) (20)
- Fetal Grafting for Parkinson's Disease: Expression of Immune Markers in Two Patients with Functional Fetal Nigral Implants (1997) (20)
- Apolipoprotein E and Alpha-1-Antichymotrypsin Genotypes Do Not Predict Time to Psychosis in Alzheimer's Disease (2002) (20)
- Distribution of plasma α1-antichymotrypsin levels in Alzheimer disease patients and controls and their genetic controls (2002) (20)
- [Neuropathology of Alzheimer's disease and mild cognitive impairment]. (2003) (20)
- Neurotrophic effects of steroids on lesion-induced growth in the hippocampus. I. The asteroidal condition (1988) (19)
- Patterns of change in the treatment of psychiatric symptoms in patients with probable Alzheimer's disease from 1983 to 2000. (2003) (19)
- Symptoms of Depression in Alzheimer's Disease, Frontal Lobe‐type Dementia, and Subcortical Dementia (1995) (19)
- Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease. (2002) (19)
- Epidermal growth factor receptor expression in demented elderly: localization to vascular endothelial cells of brain, pituitary and skin (1993) (19)
- Cerebral Blood Flow Changes after Brain Injury in Human Amyloid-Beta Knock-in Mice (2013) (18)
- Erratum: APOE*4–associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphism (1995) (18)
- Iodine-123 HIPDM brain imaging findings in subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). (1987) (18)
- No association of DAPK1 and ABCA2 SNPs on chromosome 9 with Alzheimer's disease (2009) (17)
- Association of tagSNPs in the urokinase‐plasminogen activator (PLAU) gene with Alzheimer's disease and associated quantitative traits (2007) (17)
- Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery—2018 (2018) (17)
- Lack of association of 5 SNPs in the vicinity of the insulin-degrading enzyme (IDE) gene with late-onset Alzheimer's disease (2006) (17)
- A cognitive stress test for prodromal Alzheimer's disease: Multiethnic generalizability (2019) (17)
- Gender‐specific nonrandom association between the α1‐antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease (1997) (16)
- Concussion BASICS III (2018) (16)
- Morphological Aspects of Brain Damage in Aging (1984) (16)
- Primary prevention trials in Alzheimer disease (2006) (16)
- Uncontrolled Pain and Risk for Depression and Behavioral Symptoms in Residents With Dementia. (2021) (15)
- The Psychotic Phenomenon in Probable Alzheimer's Disease (2001) (15)
- Association studies of 22 candidate SNPs with late‐onset Alzheimer's disease (2009) (15)
- Association of Apolipoprotein E in Lipoprotein Subspecies With Risk of Dementia (2020) (15)
- Apolipoprotein E Polymorphism in Alzheimer’s Disease: A Comparative Study of Two Research Populations from Spain and the United States (1998) (15)
- Cognitive mental status examinations. (1989) (15)
- Hydrocortisone differentially alters lesion-induced axon sprouting in male and female rats (1988) (14)
- Inflammatory Biomarkers and Cognitive Decline: The Ginkgo Evaluation of Memory Study (2016) (14)
- Dementia accompanying motor neuron disease. (1994) (14)
- P2-031 Amyloid deposits in transgenic PS1/APP mice do not bind the amyloid pet tracer, PIB, in the same manner as human brain amyloid (2004) (14)
- Alterations in Functional Neuroanatomical Connectivity in Alzheimer's Disease (1996) (14)
- Exploratory study of sport-related concussion effects on peripheral micro-RNA expression (2019) (14)
- Apolipoprotein E genotyping in the diagnosis of alzheimer's disease (1995) (13)
- Maintaining adherence and retention in dementia prevention trials (2006) (13)
- Contributions of Hippocampal Volume to Cognition in Healthy Older Adults (2020) (13)
- Redox-reactive autoantibodies in Alzheimer's patients' cerebrospinal fluids: Preliminary studies (2007) (13)
- The Long and the Short of Benzodiazepines and Sleep Medications: Short-Term Benefits, Long-Term Harms? (2020) (13)
- Trends in American Board of Psychiatry and Neurology specialties and neurologic subspecialties (2010) (13)
- Redox‐Reactive Autoantibodies in Cerebrospinal Fluids (2007) (13)
- A novel method of evaluating semantic intrusion errors to distinguish between amyloid positive and negative groups on the Alzheimer's disease continuum. (2020) (13)
- Caregivers as subjects of clinical drug trials: a review of human subjects protection practices in published studies of Alzheimer's disease pharmacotherapies. (2006) (13)
- Promoting interactions with basic scientists and clinicians: the NIA Alzheimer's Disease Data Coordinating Center. (2000) (13)
- Blood amyloid levels and risk of dementia in the Ginkgo Evaluation of Memory Study (GEMS): A longitudinal analysis (2019) (12)
- West Nile Virus-Induced Neurologic Sequelae—Relationship to Neurodegenerative Cascades and Dementias (2020) (12)
- Amyloid imaging with Pittsburgh Compound B (2005) (12)
- Cognitive impairment and World Trade Centre-related exposures (2021) (12)
- Semantic Intrusions and Failure to Recover From Semantic Interference in Mild Cognitive Impairment: Relationship to Amyloid and Cortical Thickness. (2018) (12)
- Independent Contributions of Dorsolateral Prefrontal Structure and Function to Working Memory in Healthy Older Adults. (2020) (12)
- High density lipoprotein and its apolipoprotein-defined subspecies and risk of dementia (2019) (12)
- Effect of education and gender adjustment on the sensitivity and specificity of a cognitive screening battery for dementia: results from the MoVIES Project. Monongahela Valley Independent Elders Survey. (1996) (12)
- Biochemistry of Senile Dementia (1985) (12)
- Amyloid Imaging with PET in Alzheimer’s Disease, Mild Cognitive Impairment, and Clinically Unimpaired Subjects (2009) (11)
- Neuropsychological correlates of single photon emission computed tomography (SPECT) in Alzheimer's disease. (1992) (11)
- A Few Corrections to Our Article (2002) (11)
- Concussion BASICS II (2018) (11)
- Dementia associated with dorsal midbrain lesion (1996) (10)
- Genetic Determinants of Survival in Patientswith Alzheimer’s Disease. (2015) (10)
- NIFID: a new molecular pathology with a frontotemporal dementia phenotype. (2004) (10)
- Invited Article: The ABPN maintenance of certification program for neurologists (2008) (10)
- Structural Neural Correlates of Double Decision Performance in Older Adults (2020) (10)
- Functional analysis of plasma α2-macroglobulin from Alzheimer's disease patients with the A2M intronic deletion (2003) (10)
- Dementia among elderly apolipoprotein E type 4/4 homozygotes: A prospective study (1995) (9)
- Utility of Plasma Neurofilament Light in the 1Florida Alzheimer’s Disease Research Center (ADRC) (2020) (9)
- Preventing Cognitive Decline and Dementia (2019) (9)
- Re: Genetic effect of α1-antichymotrypsin on the risk of Alzheimer disease (1997) (9)
- Comorbid Pain and Cognitive Impairment in a Nationally Representative Adult Population (2020) (9)
- Military-related risk factors for dementia (2018) (9)
- Acute Effects of Sport-Related Concussion on Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase L1, Total Tau, and Neurofilament Light Measured by a Multiplex Assay (2020) (9)
- Expression of fetal ALZ‐50 reactive clone 1 (FAC1) in dentate gyrus following entorhinal cortex lesion (1997) (9)
- A Workshop on Cognitive Aging and Impairment in the 9/11-Exposed Population (2021) (9)
- Association between performance on Neurology In-Training and Certification Examinations (2013) (9)
- Quantitative and statistical analyses of PET imaging studies of amyloid deposition in humans (2004) (9)
- Baseline Neuroimaging Predicts Decline to Dementia From Amnestic Mild Cognitive Impairment (2021) (8)
- Predicting resistance to amyloid-beta deposition and cognitive resilience in the oldest-old (2020) (8)
- Genetic polymorphism in the cathepsin G gene and the risk of Alzheimer's disease (2001) (8)
- Comparison of the binding of 3′-F-PiB and PiB in human brain homogenates (2008) (8)
- Use of angiotensin receptor blockers is associated with decreased risk of dementia in older adults: Secondary analysis of the Ginkgo Evaluation of Memory Study (2012) (7)
- Time‐to‐change: dementia care in COVID‐19 (2020) (7)
- Air pollution and dementia in older adults in the Ginkgo Evaluation of Memory Study (2022) (7)
- No association of dynamin binding protein (DNMBP) gene SNPs and Alzheimer's disease (2008) (7)
- O3-03-05 Human amyloid-imaging studies in controls, mild cognitive impairment and Alzheimer's disease using Pittsburg compound-B (2004) (7)
- Lack of association between alpha2-macroglobulin polymorphisms and Alzheimer's disease. (2001) (7)
- Acute Effects of Sport-Related Concussion on Serum GFAP, UCH-L1, Total Tau, and Neurofilament Light Measured by a Multiplex Assay. (2020) (7)
- Long-term Mortality in NFL Professional Football Players: No Significant Increase, but Questions Remain. (2018) (7)
- Plasma antioxidants and risk of dementia in older adults (2021) (7)
- 2012: the year in dementia (2013) (7)
- Frontal White Matter Hyperintensities and Executive Functioning Performance in Older Adults (2021) (7)
- The Establishment of a Brain Bank for the Study of Late-life Depression: A Feasibility Study of Factors Facilitating Consent (2002) (6)
- Polygenic determinants of Alzheimer's disease: modulation of the risk by alpha-1-antichymotrypsin. (1996) (6)
- Community perceptions related to brain donation: Evidence for intervention (2018) (6)
- Taking the Next Steps in the Diagnosis of Alzheimer's Disease: The Use of Biomarkers (2008) (6)
- The expanding role of genetics in the lewy body diseases: the glucocerebrosidase gene. (2009) (6)
- Epidermal Growth Factor Receptor Expression in Skin Does Not Predict Dementia in the Elderly (1997) (6)
- Association between ACT polymorphism and Alzheimer's disease (1998) (6)
- Studying the brain (2014) (6)
- Immunohistochemical study of hnRNP B1 in the postmortem temporal cortices of patients with Alzheimer's disease (2004) (6)
- I-123 Hydroxyiodobenzyl Propanediamine (HIPDM) Cerebral Blood Flow Imaging Demonstrating Transtentorial Diaschisis (1990) (5)
- Human amyloid-imaging studies with Pittsburgh Compound-B in mild cognitive impairment (MCI): Is MCI the critical period of amyloid plaque deposition? (2005) (5)
- Pain Assessments in MDS 3.0: Agreement with Vital Sign Pain Records of Nursing Home Residents (2019) (5)
- Similar enzymes, different mechanisms: COX-1 and COX-2 enzymes in neurologic disease. (2003) (5)
- Perfusion MRI assessment of cerebral blood flow and CO2 reactivity after controlled cortical impact in rats. (1997) (5)
- Effects of donepezil on motor function in patients with Alzheimer disease. (2004) (5)
- INTERLEUKIN-8 IS INCREASED IN CSF OF CHILDREN WITH SEVERE TRAUMATIC BRAIN INJURY (1998) (5)
- Patients with Alzheimer's Disease Who Live at Home: The Challenge of Medication Taking (2011) (5)
- Lack of association of two chromosome 10q24 SNPs with Alzheimer's disease (2006) (5)
- Comparison of the design differences between the Ginkgo Evaluation of Memory study and the Guidage study (2008) (5)
- CR 1 and the “ Vanishing Amyloid ” Hypothesis of Alzheimer ’ s Disease (2013) (4)
- Optimal time window for standardized uptake ratio as a simplified measure of PIB retension (2007) (4)
- Alcohol Consumption, Brain Amyloid-β Deposition, and Brain Structural Integrity Among Older Adults Free of Dementia. (2020) (4)
- P1-256: Cerebellar amyloid in a case of early-onset dementia with a presenilin-1 mutation: Correlation to clinical phenotype (2008) (4)
- Proximal improvement and higher-order resting state network change after multidomain cognitive training intervention in healthy older adults (2022) (4)
- Association of Cognitive Impairment With Free Water in the Nucleus Basalis of Meynert and Locus Coeruleus to Transentorhinal Cortex Tract (2021) (4)
- Association between single moderate to severe traumatic brain injury and long-term tauopathy in humans and preclinical animal models: a systematic narrative review of the literature (2022) (4)
- Agreement of Minimum Data Set 3.0 depression and behavioral symptoms with clinical diagnosis in a nursing home (2020) (4)
- CME Practice parameter : Diagnosis of dementia ( an evidence-based review ) Report of the Quality Standards Subcommittee of the American Academy of Neurology (2001) (4)
- Cholinergic Changes and Synaptic Alterations in Alzheimer’s Disease (1994) (4)
- Simplified quantification of PIB amyloid imaging PET studies (2005) (4)
- The role of big data in understanding late-life cognitive decline: E Unum, Pluribus. (2014) (4)
- Managing Alzheimer's disease (1985) (4)
- Alzheimer Disease Subjects with Psychosis Have Increased Schizotypal Symptoms Before Dementia Onset (2005) (4)
- Quality of opioid prescribing in older adults with or without Alzheimer disease and related dementia (2021) (4)
- In vivo amyloid deposition and neuropathological findings after humanized amyloid β-specific monoclonal antibodies therapy in a patient with Alzheimer's disease (2009) (4)
- Strain differences and laminar localization of structural neurochemical changes in aging rat (1985) (4)
- Antemortem biomarker support for a diagnosis of clinically probable chronic traumatic encephalopathy (2017) (4)
- Perspectives on assessing benefits and risks in clinical trials for Alzheimer’s disease (2006) (3)
- Cerebrospinal Biomarkers in Alzheimer Disease-Potential Roles as Markers of Prognosis and Neuroplasticity. (2016) (3)
- Acute and chronic effects of single dose memantine after controlled cortical impact injury in adult rats. (2019) (3)
- Cingulo-opercular and frontoparietal control network connectivity and executive functioning in older adults (2021) (3)
- Chapter 2 Alzheimer's Disease (2007) (3)
- HYPOTHERMIA REDUCES ACUTE INFLAMMATION AFTER TRAUMATIC BRAIN INJURY IN RATS† 317 (1996) (3)
- Genetic polymorphism in the persyn (γ-synuclein) gene and the risk of Alzheimer's disease (1999) (3)
- Association between A Community-Based Dementia and Study Elevated TSH: (1996) (3)
- Case-cohort study of plasma phospholipid fatty acid profiles, cognitive function, and risk of dementia: a secondary analysis in the Ginkgo Evaluation of Memory Study. (2021) (3)
- [Neurobiology and molecular biology of Alzheimer's disease]. (2002) (3)
- Acetylcholine synthesis in human CSF: Implications for study of central cholinergic metabolism (1989) (3)
- Structural MRI and Molecular PET Imaging (AV45 and AV1451) in the Diagnosis of Chronic Traumatic Encephalopathy In Vivo: Study of a Retired NFL Player (P4.046) (2016) (3)
- O3-04-02: The Ginkgo in evaluation of memory (GEM) study: Primary outcomes in a longitudinal dementia prevention trial (2008) (3)
- PET Imaging of Tau Pathology and Amyloid-β, and MRI for Alzheimer's Disease Feature Fusion and Multimodal Classification. (2021) (3)
- P-029 Correlation of regional in VIVO pittsburgh compound-B (PIB) retention with in vitro PIB, Aβ levels, and amyloid plaque density: Validation of PIB-PET in postmortem human brain (2007) (3)
- Alzheimer Disease: The “State of the State” (2013) (3)
- Searching for the holy grail: What is the structural correlate of cognition? (1995) (3)
- Utility of Amyloid PET Scans in the Evaluation of Patients Presenting with Diverse Cognitive Complaints. (2018) (3)
- Gray matter atrophy associated with extrapyramidal signs in the Lewy body variant of Alzheimer's disease. (2012) (3)
- Amyloid PET imaging in clinical practice (2013) (3)
- Alzheimer Research Forum Live Discussion: sports concussions, dementia, and ApoE genotyping: what can scientists tell the public? What's up for research? (2009) (3)
- Electroencephalographic correlates of periventricular white matter lesions in probable Alzheimer's disease. (1995) (3)
- Arterial stiffness is associated with amyloid deposition in the brain independent of blood pressure (2013) (3)
- Turning over a new leaf (2008) (3)
- The nature of behavioral disorders in human Klüver-Bucy syndrome (1995) (2)
- Acetylcholinesterase changes in people with mild cognitive impairment implications for hippocampal plasticity (2002) (2)
- O4-01-07 Episodic memory function correlates with neurofibrillary pathology but not cholinergic enzyme changes in the hippocampus of normal elderly and subjects with mild cognitive impairment (2004) (2)
- Appendix C: Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review): Report of the quality standards subcommittee of the American academy neurology (2007) (2)
- 22R-Hydroxycholesterol and 9-cis-retinoic acid induce ABCA1 transporter expression and cholesterol efflux in brain cells and decrease Aβ secretion* (2003) (2)
- Inflammatory Process in the Pathobiology of Secondary Damage After Traumatic Brain Injury (1997) (2)
- Risk of Dementia Differs across Lifestyle Engagement Subgroups: A Latent Class and Time to Event Analysis in Community-Dwelling Older Adults. (2021) (2)
- Stability of sialogangliosides in kindled hippocampus (1986) (2)
- Chronic traumatic encephalopathy: clinical‐biomarker correlations and current concepts in pathogenesis (2014) (2)
- Response of Amino Acid Neurotransmitters and Metabolites by APOE Genotype (1999) (2)
- Longitudinal PIB measures in control, MCI, and AD subjects (2008) (2)
- O2-01-05 Incident psychiatric symptoms predict conversion to dementia in mild cognitive impairment subgroups (2004) (2)
- P3-284 5-Lipoxygenase protein is elevated in the hippocampus of Alzheimer's disease patients (2004) (2)
- A Tensorized Multitask Deep Learning Network for Progression Prediction of Alzheimer’s Disease (2022) (2)
- Genetic polymorphism in the persyn (gamma-synuclein) gene and the risk of Alzheimer's disease. (1999) (2)
- Florbetapir scanning excludes Alzheimer's disease in a retired NFL player with delayed cognitive impairment (2013) (2)
- The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease (2020) (2)
- Higher-order resting state network association with the useful field of view task in older adults (2021) (2)
- WHAT ARE THE KEY MECHANISMS OF SECONDARY DAMAGE AFTER TRAUMATIC BRAIN INJURY?: 16 (1999) (2)
- Efficacy of galantamine in probable vascular dementia: an effective option for managing behavioural problems (2002) (2)
- P1-231: Correlation of amyloid deposition with local and distal glucose metabolism in cognitively normal elderly, MCI and Alzheimer's disease (2008) (2)
- Moderate alcohol intake is associated with lower dementia incidence: results from the Ginkgo Evaluation of Memory Study (GEMS) (2009) (2)
- [O-15] Water and PIB PET imaging in Alzheimer's disease and mild cognitive impairment (2006) (2)
- IC-103-04 Amyloid burden correlates with cognitive function in normal aging, MCI and AD (2006) (2)
- The longitudinal impact of the COVID-19 pandemic on health behaviors, psychosocial factors, and cognitive functioning in older adults (2022) (2)
- IC-103-05 Pittsburgh compound-B four years later: What have we learned, what lies ahead? (2006) (2)
- The association between head motion during functional magnetic resonance imaging and executive functioning in older adults (2022) (2)
- Subject Index Vol. 6,1995 (1995) (1)
- PIB PET 3-site stability study (2007) (1)
- P2-242 Segmentation comparison between the MNI and the University of Pittsburgh elderly template (2004) (1)
- Low binding of the amyloid PET tracer, PIB, to transgenic PS1/APP mouse brain compared to human AD brain explained by Bmax (2005) (1)
- IC-P-016 Imaging of cerebral amyloid angiopathy with Pittsburgh compound B (2006) (1)
- Histological characterization of PIB binding to amyloid plaques in Alzheimer’s disease (2005) (1)
- O2-05-03: Inclusion body myopathy with paget disease of the bone and frontotemporal dementia: New families, a novel mutation, and a new clinical presentation (2008) (1)
- CLINICAL BIOMARKER EVIDENCE FOR TARGET ENGAGEMENT, REDUCTION OF SYNAPTIC DAMAGE AND DISEASE MODIFICATION IN ALZHEIMER’S PATIENTS TREATED WITH CT1812 (2019) (1)
- Pharmacologic and pharmacokinetic equivalence studies of GE-067 to PiB (2009) (1)
- Amyloid imaging of cerebral amyloid angiopathy (2007) (1)
- Gender-specific aging reductions in [11C-carbonyl] WAY100635 binding: Not an effect of atrophy (2000) (1)
- Diffusion tensor imaging (DTI) findings in adult civilian, military, and sport-related mild traumatic brain injury (mTBI): a systematic critical review (2017) (1)
- Genome‐wide meta‐analysis of age‐related cognitive decline in population‐based older individuals (2021) (1)
- Association of longitudinal cognitive decline with diffusion MRI in Gray Matter, Amyloid, and Tau deposition (2022) (1)
- Principles of Geriatric Neurology (Contemporary Neurology Series, No. 38) (1993) (1)
- DOPAMINE-4 RECEPTOR AND COGNITION IN ALZHEIMER's DISEASE (1999) (1)
- RESPONSE LETTER TO DR. THOMAS FINUCANE (2005) (1)
- POSTTRAUMATIC HYPOTHERMIA DECREASES MORTALITY AFTER SEVERE CONTROLLED CORTICAL IMPACT IN RATS. (1995) (1)
- Diagnostic Classifications: Relationship to the Neurobiology of Dementia (2011) (1)
- A study of the longitudinal changes in multiple cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers on converter and non‐converter Alzheimer's disease subjects with consideration for their amyloid beta status (2022) (1)
- The Effects of Transcutaneous Vagus Nerve Stimulation on Functional Connectivity Within Semantic and Hippocampal Networks in Mild Cognitive Impairment (2022) (1)
- O3-02-03 Heritability of psychosis in Alzheimer disease (2004) (1)
- A PHASE 1 SAFETY TRIAL OF THE Aβ OLIGOMER RECEPTOR ANTAGONIST CT1812 (2017) (1)
- Re: Genetic effect of alpha 1-antichymotrypsin on the risk of Alzheimer disease. (1997) (1)
- The Broad Range of Research in Alzheimer’s Disease and Related Dementias (2022) (1)
- Correlations between sleep disturbance and brain structures associated with neurodegeneration in the National Alzheimer's Coordinating Center Uniform Data Set (2022) (1)
- Biomedical discovery through the integrative biomedical knowledge hub (iBKH). (2023) (1)
- Amyloid imaging with Pittsburgh Compound-B in late-life depression (2005) (1)
- P4-038 Classification of vascular dementia in the cardiovascular health study cognition study (2004) (1)
- Policy Forum 2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease (2014) (1)
- P2-285 Voxel-based analyses of pittsburgh Compound-B and FDG in AD (2006) (1)
- Pentraxin inflammatory biomarkers and associations with risk of dementia and Alzheimer's disease in older adults (2013) (1)
- Functional Neural Correlates of a Useful Field of View (UFOV)-Based fMRI Task in Older Adults. (2021) (1)
- O1-01-08 The Ginkgo in evaluation of memory (GEM) study design, recruitment, and incident dementia rates: A preliminary report (2007) (1)
- Neuropathology of mild cognitive impairment in the elderly (2005) (1)
- Alzheimer research forum live discussion: Memantine: Implications for treating Alzheimer's (2005) (1)
- P4-039 Clinical and MRI factors for vascular dementia in the cardiovascular health study cognition study (2004) (1)
- Recovery of Function in Senile Dementia of the Alzheimer Type (1984) (1)
- Assess the documentation of cognitive tests and biomarkers in electronic health records via natural language processing for Alzheimer's disease and related dementias (2022) (1)
- The Human Alzheimer Disease Project: Answering the Call. (2016) (1)
- Cognitive and Neuropathological Correlates of Full-Length and Truncated-Pyroglutamate-Modified Amyloid-beta Forms in Mild Cognitive Impairment and Early Alzheimer's Disease (P04.217) (2013) (0)
- P4-568 PROSPECTIVE ESCITALOPRAM DECREASES LONGITUDINAL CSFAb CONCENTRATION IN COGNITIVELY NORMAL ELDERLY SUBJECTS: A RANDOMIZED DOSE FINDING STUDY (2017) (0)
- Augmenting cognitive training in older adults with transcranial direct current stimulation: Initial results from the Phase III ACT trial and new directions (2022) (0)
- Apolipoprotein D distribution in normal and Alzheimer's brains: Implications for its role in the pathogenesis of Alzheimer's disease (2000) (0)
- The application of amyloid-imaging to the diagnosis and treatment of Alzheimer’s disease (2005) (0)
- ASSOCIATION OF APOLIPOPROTEINS AND APOLIPOPROTEIN SUBSPECIES WITH HIPPOCAMPAL AND WHITE MATTER LESION VOLUME (2018) (0)
- O3-06-08 Pattern of amyloid plaque deposition with Pittsburgh compound-B (PIB) in mild cognitive impairment (2006) (0)
- MAC‐1 ANTIBODIES ATTENUATE NEUTROPHIL ACCUMULATION AFTER TRAUMATIC BRAIN INJURY IN RATS. (1995) (0)
- The Long and the Short of Benzodiazepines and Sleep Medications: Short-Term Benefits, Long-Term Harms? (2020) (0)
- Cluster analysis of PIB and FDG PET measures in control, MCI, and Alzheimer's disease subjects (2008) (0)
- PRELIMINARY RESULTS ON THE IMPACT OF APOE GENOTYPES ON CEREBROSPINAL FLUID (CSF) EXCITATORY AMINO ACIDS (EAA) AND METABOLITES IN TRAUMATIC BRAIN INJURED (TBI) ADULTS (1999) (0)
- The Association between Air Pollution and Depression: Evidence from the Ginkgo Evaluation of Memory Study (2018) (0)
- TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE: TRANSLATING BASIC RESEARCH FINDINGS (2008) (0)
- PREDICTING RESILIENCY AGAINST AMYLOID-BETA DEPOSITION, COGNITIVE IMPAIRMENT, AND THEIR COMBINATION IN THE OLDEST-OLD (2018) (0)
- Lifestyle Complexity and Dementia Risk: Examining Moderation by APOE Genotype and Mild Cognitive Impairment (2020) (0)
- The Effect of Anxiety on Regional Brain Volumes in the National Alzheimer’s Coordinating Center Uniform Data Set (2020) (0)
- Trans-cortical correlations of pittsburgh compound-B in cognitively normal elderly, MCI and Alzheimer's: Implications for the natural history of amyloid deposition (2010) (0)
- Multivariate analysis of PIB PET imaging studies (2006) (0)
- P2-019: Differential labeling of amyloid plaques and tangles with 6-CN-PiB: Implications for in vivo PiB PET imaging (2008) (0)
- Temporoparietal hypometabolism is common in FTLD and is associated with imaging diagnostic errors (2011) (0)
- Use of partial least squares to relate yearly PiB DVR to clinical covariates in non-demented subjects (2009) (0)
- A-10 Role of Fluid Cognitive Status in the Association of Frontoparietal Control and Cingulo-Opercular Networks with the Useful Field of View Task: Implications for Cognitive Training in Aging (2021) (0)
- P4-131 Association of the APOE promoter polymorphisms with late-onset Alzheimer's disease (2004) (0)
- IC-P-019 LONGITUDINAL ACCUMULATION OF b AMYLOID ON PET IN DEMENTIAWITH LEWY BODIES AND RELATIONSHIP TO CLINICAL DISEASE PROGRESSION PREDICTING RESILIENCYAGAINST AMYLOID-BETA DEPOSITION, COGNITIVE IMPAIRMENT, AND THEIR COMBINATION IN THE OLDEST-OLD (2018) (0)
- P4-332 LXR ligand treatment in vitro and in vivo is followed by ABCA1 upregulation and decrease in AB secretion (2004) (0)
- Brain PET Oral 6: Neurodegenerative Disorders (2009) (0)
- QUANTIFICATION OF NORMAL BRAIN AGING USING FULLY DEFORMABLE REGISTRATION (2012) (0)
- Your Questions Answered: ALZHEIMERʼS (2006) (0)
- Contents Vol. 15, 1996 (1996) (0)
- P1-231 Post-injury increases in NFKB precede changes in amyloid precursor protein and amyloid beta following traumatic brain injury (2004) (0)
- O1-01-01 Synaptic alterations in inferior temporal lobe in Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI) (2006) (0)
- TAU IMAGING WITH [18F]T807/AV-1451 IN ATHLETES WITH POST-CONCUSSIVE COMPLAINT AND CONTROLS (2017) (0)
- Cognitive trajectories associated with beta-amyloid deposition in the nondemented oldest-old (2012) (0)
- Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease (2023) (0)
- Transcutaneous vagal nerve stimulation effects on the salience network in patients with amnestic mild cognitive impairment (2020) (0)
- Alzheimer disease risk factors--reply. (2014) (0)
- P2-199 Perfusion MRI study of dementia: preliminary results (2004) (0)
- A transfer learning approach based on gradient boosting machine for diagnosis of Alzheimer’s disease (2022) (0)
- Alzheimer ' s disease ) gene with OLR 1 oxidised LDL receptor 1 (-UTR polymorphisms of the ′ Association of 3 (2003) (0)
- Newer glucose-lowering drugs and risk of dementia: A systematic review and meta-analysis of observational studies. (2023) (0)
- P2-097: Amyloid-imaging in dementias of uncertain etiology with Pittsburgh compound B (2008) (0)
- Investigation of the independent role of a rare APOE variant (L28P; APOE*4Pittsburgh) in late-onset Alzheimer disease (2022) (0)
- P4-075 Psychotic symptoms identify subtypes of AD: a prospective validation study (2004) (0)
- The type 1 interleukin‐1 receptor is essential for multiple aspects of brain inflammation (2008) (0)
- P2-328 Imaging of cerebral amyloid angiopathy with Pittsburgh Compound B (2006) (0)
- Cognitive trajectories associated with beta-amyloid deposition in the nondemented oldest-old (2012) (0)
- Development and Application of b-Amyloid Imaging Agents in Alzheimer’s Disease (2016) (0)
- EFFECTS OF VITAMIN B12 DEFICIENCY ON COGNITIVE FUNCTIONING IN ELDERLY (1999) (0)
- Semantic information processing in Alzheimer's disease (2000) (0)
- Contents Vol.19, 2019 (2020) (0)
- Neuropsychiatric Inventory--Questionnaire Version (2014) (0)
- P2-268 Amyloid deposition in presymptomatic familial Alzheimer’s disease (2006) (0)
- Plasma phospholipid fatty acids, cognitive function, and risk of dementia among older adults (2020) (0)
- Longitudinal study of amyloid deposition in carriers of presenilin-1, presenilin-2 and APP mutations (2009) (0)
- P4-120 The calcium sensing receptor in Alzheimer disease susceptibility (2004) (0)
- Levels and trajectories of domain‐specific cognition differ across lifestyle engagement subgroups of older adults (2021) (0)
- Amyloid Deposition and Hippocampal Volume as Predictors of Incident Dementia in Non-Demented Very Elderly Subjects (IN3-2.004) (2013) (0)
- Front & Back Matter (2021) (0)
- Amyloid imaging in nondemented oldest-old (2011) (0)
- Regional Brain Volumes Associated With Depression in the National Alzheimer’s Coordinating Center Uniform Data Set (2020) (0)
- THE RELATIONSHIP BETWEEN HISPANIC ETHNICITY, AMYLOID LOAD AND APOE4 CARRIER STATUS (2019) (0)
- β-amyloid plaques in a PiB-PET negative subject: Implications for sensitivity of amyloid imaging in vivo (2009) (0)
- Subject Index Vol. 15, 1996 (1996) (0)
- PREDICTING RESILIENCY AGAINST AMYLOID-BETA DEPOSITION, COGNITIVE IMPAIRMENT, AND THEIR COMBINATION IN THE OLDEST-OLD (2018) (0)
- Sources of variability in the PIB PET tissue time–activity data (2008) (0)
- Higher white matter hyperintensity load adversely affects pre-post proximal cognitive training performance in healthy older adults (2022) (0)
- Genome-Wide Association Study of Incident Dementia in a Community-Based Sample of Older Subjects (2022) (0)
- DOPAMINE RECEPTOR CORRELATES OF PSYCHOSIS IN DEMENTIA (1999) (0)
- Only within resting state network connectivity of the frontoparietal control and Cingulo Opercular networks predict useful field of view performance (2021) (0)
- ASSOCIATION OF HDL SUBSPECIES WITH OR WITHOUT APOLIPOPROTEIN E WITH ALZHEIMER’S DISEASE NEUROPATHOLOGY: THE GINKGO EVALUATION OF MEMORY STUDY (2017) (0)
- Interleukin-8 is Increased in CSF of Children with Severe Traumatic Brain Injury • 240 (1998) (0)
- P3-579 ASSOCIATION OFAPOLIPOPROTEINS AND APOLIPOPROTEIN SUBSPECIES WITH HIPPOCAMPAL ANDWHITE MATTER LESION VOLUME (2018) (0)
- The evolution of geriatric neurology. (2019) (0)
- 470. No increased severity of neuropathologic features in Alzheimer’s disease with psychosis (2000) (0)
- Supplements for Brain Health Show No Benefit (2020) (0)
- Plasma antioxidants and phospholipids and brain imaging biomarkers among non‐demented older adults (2021) (0)
- Amyloid imaging in the 80+ population and cognitive trajectories (GEMS) (2015) (0)
- Early prediction of Alzheimer's disease and related dementias using real-world electronic health records. (2023) (0)
- 45. Gender differences in aging effect on the 5-HTlA receptor with [11C-carbonyl]way100635 PET (2000) (0)
- Hospitalization For Pneumonia Is Associated With Increased Risk Of Dementia In Older Adults (2012) (0)
- A-3 Cingulo-Opercular and Frontoparietal Control Network Connectivity and Executive Functioning in Older Adults (2021) (0)
- Longitudinal changes in fibrillar amyloid-beta deposition across the cognitive spectrum: Effect of the APOE4 allele (2011) (0)
- S4-02-01 Overview of the concept of MCI (2006) (0)
- Looking Ahead: Dementia and Alzheimer's disease in the 21st century (2012) (0)
- HUMAN AMYLOID IMAGING IN CONTROLS, MCI AND AD WITH THE THIOFLAVIN-T DERIVATIVE, PIB (2003) (0)
- UCHL-1 in the pathogenesis of sporadic PD and DLB. S1-04-04 DEMENTIA WITH LEWY BODIES (2006) (0)
- Amyloid imaging in nondemented oldest old (2011) (0)
- IC-P2-124: Gray matter changes in cognitively normal control subjects with PiB retention (2008) (0)
- Longitudinal study of amyloid deposition in carriers of presenilin-1, presenilin-2 and APP mutations (2009) (0)
- ROLE OF GENETIC BACKGROUND: INFLUENCE OF APOLIPOPROTEIN E GENOTYPE IN ALZHEIMER'S DISEASE AND AFTER HEAD INJURY (2001) (0)
- Alzheimer ’ s disease : The right drug , the right time Lessons from failed clinical trials can improve the development of Alzheimer ’ s disease – modifying therapies (2018) (0)
- IC-P2-110: Classification of amyloid-positivity in cognitively normal elderly controls: Comparison of objective approaches with visual reads (2008) (0)
- Assessing the threshold for in vivo detection of amyloid-beta plaques (2010) (0)
- Correspondence (1995) (0)
- CEREBRAL AMYLOID-β AND GAIT SPEED IN OLDER ADULTS WITHOUT DEMENTIA: INFLUENCE OF COGNITION AND APOE-E4 GENOTYPE (2016) (0)
- Negative results from the secondary outcomes analysis of the Ginkgo Evaluation of Memory Study of Ginkgo biloba (2010) (0)
- A TWO-PART, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 1 STUDY OF THE SAFETY AND PHARMACOKINETICS OF SINGLE AND MULTIPLE ASCENDING DOSES OF CT1812 IN HEALTHY VOLUNTEERS (2016) (0)
- Identification of temporal lobe structures associated with visual naming using voxel-based analysis of MRI scans in probable Alzheimer's Disease (2000) (0)
- Neuropsychological correlates of Single Photon Emission Tomography (SPECT) in Alzheimer's disease (1989) (0)
- Acute changes in Alzheimer's disease-related markers after human head trauma (2000) (0)
- Anti-amyloid approaches to treating Alzheimer's disease (2000) (0)
- Over-representation of the APOE*4 allele in autopsy confirmed early- and late-onset sporadic Alzheimer`s disease (1994) (0)
- Meta‐analysis of age‐related cognitive decline reveals a novel locus for the attention domain and implicates a COVID‐19 related gene for global cognitive function (2022) (0)
- Regional differences in amyloid load and cortical cholinergic plasticity during the progression of Alzheimer's disease (2010) (0)
- Antihypertensive drugs decrease risk of Alzheimer disease Ginkgo Evaluation of Memory Study (0)
- β-amyloid plaques in a PiB-PET negative subject: Implications for sensitivity of amyloid imaging in vivo (2009) (0)
- Reduction of neurogranin immunostaining in the hippocampus of post‐mortem brain of Alzheimer’s disease (2020) (0)
- Higher-order resting state network association with the useful field of view task in older adults (2021) (0)
- Patterns of correlation between Aβ deposition and glucose metabolism across the spectrum of mild cognitive impairment to Alzheimer's disease (2009) (0)
- IC-103-03 Amyloid deposition in presymptomatic familial Alzheimer’s disease (2006) (0)
- PLASMA AMYLOID, INFLAMMATORY MARKERS, AND TIME TO DEMENTIA IN THE GINKGO EVALUATION OF MEMORY STUDY (2019) (0)
- Examining risk of dementia in lifestyle engagement subgroups of community‐dwelling older adults: A latent class approach (2020) (0)
- 469. Evidence of increased neuronal dysfunction in Alzheimer’s disease with psychosis (2000) (0)
- P3-014 Excess cognitive impairment in MCI and early Alzheimer disease predicts the later emergence of psychosis (2006) (0)
- P3-428 Stability of nicotinic acetylcholine receptor binding in the frontal and temporal cortex of subjects with mild cognitive impairment (2006) (0)
- Binding of the amyloid-imaging PET tracer, Pittsburgh Compound-B, to post-mortem human brain tissue from the AN-1792 immunotherapy trial (2005) (0)
- P4-353: The Ginkgo Evaluation of Memory (GEM) Study: Lessons on adherence and retention in dementia primary prevention trials (2008) (0)
- Ginkgo biloba and Cognitive Decline—Reply (2010) (0)
- Genome‐wide association study of plasma apolipoprotein E levels and risk of dementia in older adults (2022) (0)
- How should we design studies for stroke prevention? (2003) (0)
- IC-P-001 Imaging Alzheimer’s pathology in late-life depression with PIB-PET (2006) (0)
- IC-P2-102: Differential labeling of amyloid plaques and tangles with 6-CN-PiB: Implications for in vivo PiB PET imaging (2008) (0)
- P1-296 HTR2A genotype, depression, and risk for psychosis onset in Alzheimer’s disease (2006) (0)
- PERCENTAGE OF INTRUSION ERRORS ON THE LASSI-L COGNITIVE STRESS TEST DISCRIMINATES BETWEEN AMYLOID POSITIVE AND AMYLOID NEGATIVE INDIVIDUALS WITH AMNESTIC MILD COGNITIVE IMPAIRMENT AND EARLY DEMENTIA (2019) (0)
- Urea cycle and Alzheimer's disease (2009) (0)
- Electroencephalography and survival in patients with Alzheimer's disease (1998) (0)
- The Impact of Sleep Disturbance on Regional Brain Volumes (2020) (0)
- How do different economic models of care impact the care of patients with dementia ? (2003) (0)
- Preventing Dementia: Many Issues and Not Enough Time. (2017) (0)
- P2-369 Correlation analysis of the histofluorescence of an analogue of Pittsburgh Compound-B and Aβ peptide levels in Alzheimer’s disease (2006) (0)
- P4-078 Alpha-1 antichymotrypsin (ACT or serpina3) may affect age-at-onset of Alzheimer's disease (2004) (0)
- Factors Influencing Clinical Correlates of Chronic Traumatic Encephalopathy (CTE): a Review (2016) (0)
- SYNAPSE LOSS IN BRODMANN AREA 9 IN ALZHEIMER'S DISEASE PATIENTS: 15 (1987) (0)
- APOLIPOPROTEIN E IN LIPOPROTEIN SUBSPECIES AND RISK OF DEMENTIA (2019) (0)
- The impact of accuracy on functional neural correlates of the useful field of view (UFOV) task (2021) (0)
- Another data/rhetoric mismatch on donepezil. Authors' reply (2005) (0)
- Contents Vol. 6, 1995 (1995) (0)
- P4-139 Lack of association between polymorphisms in the brain-derived neurotrophic factor (BDNF) and sporadic late-onset Alzheimer's disease in caucasians (2004) (0)
- A critique of the draft DSM-V criteria (2010) (0)
- Mediation of Reduced Hippocampal Volume by Cerebral Amyloid Angiopathy in Pathologically Confirmed Patients with Alzheimer's Disease. (2023) (0)
- QUINOLINIC ACID IS INCREASED IN CSF AND ASSOCIATED WITH MORTALITY IN HUMAN HEAD INJURY (1997) (0)
- Longitudinal Changes in Amyloid Deposition in Normal Elderly, Mild Cognitive Impairment and Alzheimer's disease (2010) (0)
- Possible Role of Orexin in the Pathogenesis of Alzheimer Disease (2017) (0)
- P2-329 Amyloid burden correlates with cognitive function in normal aging, MCI and AD (2006) (0)
- DOPAMINE RECEPTOR GENETIC VARIATION AND MOTIVATIONAL DISTURBANCE IN ALZHEIMER's DISEASE (1999) (0)
- Brief communication Association of CLU and PICALM variants with Alzheimer's disease (2012) (0)
- Incidence of Mild Cognitive Impairment in the CHS Cognition Study (S24.001) (2012) (0)
- SEMANTIC INTRUSION ERRORS DIFFERENTIATE AMYLOID POSITIVE AMNESTIC MILD COGNITIVE IMPAIRMENT FROM COGNITIVELY HEALTHY CONTROLS (2019) (0)
- EFFECT OF AGE, GENDER, ETHNICITY, COGNITION AND APOE GENOTYPE ON AMYLOID LOAD AMONG NORMAL, MCI AND MILD DEMENTIA SUBJECTS USING [F-18] FLORBETABEN (2018) (0)
- Statistical modeling of longitudinal PiB retention (2010) (0)
- Neuropsychiatric Inventory with Caregiver Distress Scale 1998 (2004) (0)
- Association between single moderate to severe traumatic brain injury and long-term tauopathy in humans and preclinical animal models: a systematic narrative review of the literature (2022) (0)
- Amyloid precursor protein and amyloid-β-production are altered by caspase inhibition after traumatic brain injury in humanized Aβ mice (2000) (0)
- Arterial stiffness is associated with amyloid deposition in the brain independent of blood pressure (2013) (0)
- P4-056 AD subjects with psychosis have increased subsyndromal psychotic symptoms prior to dementia onset (2004) (0)
- omarker for assessing signals of efficacy in early-stage AD clinical trials. P2-327 NEUROIMAGE STEREOLOGY: A MARKER FOR BRAIN AGING AND DEMENTIA (2006) (0)
- Trans-cortical correlations of Pittsburgh Compound-B in cognitively normal elderly, MCI and AD: Implications for the natural history of amyloid deposition (2010) (0)
This paper list is powered by the following services:
Other Resources About Steven T. DeKosky
What Schools Are Affiliated With Steven T. DeKosky?
Steven T. DeKosky is affiliated with the following schools: